| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11095-014-1507-Z |
| P698 | PubMed publication ID | 25231009 |
| P2093 | author name string | Seong-Hoon Jeong | |
| Min-Ju Kim | |||
| Young-Wook Choi | |||
| Jo-Eun Seo | |||
| Sangkil Lee | |||
| Dong-Ho Oh | |||
| Sang-Ok Jeon | |||
| Jeong-Won Kang | |||
| P2860 | cites work | Sustained release of salmon calcitonin in vivo from lactide: glycolide copolymer depots | Q70743109 |
| Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin | Q72280639 | ||
| Chitosan films and hydrogels of chlorhexidine gluconate for oral mucosal delivery | Q73293406 | ||
| Transdermal iontophoretic delivery of salmon calcitonin | Q73876581 | ||
| Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy | Q74769093 | ||
| A mechanistic analysis to characterize oramucosal permeation properties | Q78056672 | ||
| Delivery of macromolecules across oral mucosa from polymeric hydrogels is enhanced by electrophoresis (iontophoresis) | Q86442167 | ||
| Buccal iontophoretic delivery of atenolol.HCl employing a new in vitro three-chamber permeation cell | Q31883373 | ||
| Buccal mucosa as a route for systemic drug delivery: a review. | Q33913811 | ||
| Enhanced percutaneous delivery of recombinant human epidermal growth factor employing nano-liposome system | Q34116284 | ||
| Factors and strategies for improving buccal absorption of peptides. | Q34167000 | ||
| Novel mechanisms and devices to enable successful transdermal drug delivery | Q34334041 | ||
| Possible mechanisms of the analgesic action of calcitonin | Q34635947 | ||
| Iontophoretic drug delivery. | Q35690690 | ||
| Buccal penetration enhancers--how do they really work? | Q36127924 | ||
| Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs | Q36530971 | ||
| Transbuccal delivery of 5-fluorouracil: permeation enhancement and pharmacokinetic study | Q41825762 | ||
| Biophysical assessment of DC iontophoresis and current density on transdermal permeation of methotrexate | Q41894186 | ||
| Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin | Q43597695 | ||
| Permselective characteristics of rabbit buccal mucosa | Q43619722 | ||
| Characterization of the influence of polyol fatty acid esters on the permeation of diclofenac through rat skin | Q43715328 | ||
| Transdermal iontophoresis of insulin. V. Effect of terpenes | Q44356535 | ||
| Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation | Q44840846 | ||
| N-acetylcysteine inhibits Na+ absorption across human nasal epithelial cells | Q44998285 | ||
| Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies. | Q45003129 | ||
| Preparation and characterization of salmon calcitonin-sodium triphosphate ionic complex for oral delivery | Q45353650 | ||
| Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro | Q46374151 | ||
| Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin | Q46489750 | ||
| In vivo iontophoretic delivery and pharmacokinetics of salmon calcitonin | Q46501721 | ||
| Electrically induced transport of macromolecules through oral buccal mucosa | Q46738349 | ||
| Enhancement of nasal absorption of large molecular weight compounds by combination of mucolytic agent and nonionic surfactant | Q46794191 | ||
| N-Acetyl-L-cysteine and its derivatives activate a Cl- conductance in epithelial cells | Q49021235 | ||
| Enhanced oromucosal delivery of progesterone via hexosomes. | Q50915876 | ||
| Mucus as a barrier to the permeability of hydrophilic and lipophilic compounds in the absence and presence of sodium taurocholate micellar systems using cell culture models | Q60546087 | ||
| Diffusion of naltrexone across reconstituted human oral epithelium and histomorphological features | Q61454933 | ||
| Plasma kinetics and urinary excretion of exogenous human and salmon calcitonin in man | Q67018064 | ||
| Degradation of synthetic salmon calcitonin in aqueous solution | Q67977718 | ||
| P433 | issue | 3 | |
| P921 | main subject | drug delivery | Q1392806 |
| P304 | page(s) | 929-940 | |
| P577 | publication date | 2014-09-18 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Strategic approaches for enhancement of in vivo transbuccal peptide drug delivery in rabbits using iontophoresis and chemical enhancers | |
| P478 | volume | 32 |
Search more.